Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: Past present and future

Journal of the National Cancer Institute

Volumn 97, Issue 6, 2005, Pages 407-409

  Engels, Eric A ^a   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CANCER; BREAST CANCER; BURKITT LYMPHOMA; CANCER GRADING; CANCER PREVENTION; CANCER RISK; CELLULAR IMMUNITY; CLINICAL TRIAL; COLON CANCER; DISEASE ASSOCIATION; EDITORIAL; EPIDEMIC; EPSTEIN BARR VIRUS; GENE MUTATION; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOBLASTIC LYMPHOMA; INCIDENCE; KAPOSI SARCOMA; LIFE EXPECTANCY; LIVER CANCER; LONG TERM CARE; LUNG CANCER; META ANALYSIS; NONHODGKIN LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK FACTOR; SMOKING; T CELL DEPLETION; UTERINE CERVIX CANCER; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE; WART VIRUS; AIDS RELATED COMPLEX; B CELL LYMPHOMA; CD4+ T LYMPHOCYTE; LYMPHOCYTE COUNT; NOTE; PATHOGENICITY; UNITED STATES; VIROLOGY; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CALIFORNIA; CD4-POSITIVE T-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; INCIDENCE; LIFE EXPECTANCY; LYMPHOCYTE COUNT; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; NEW YORK CITY; RISK FACTORS; SARCOMA, KAPOSI; TUMOR VIRUS INFECTIONS;

EID: 14944372533     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji085     Document Type: Editorial

References (19)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD, HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338: 853-60.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpeper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
3. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989;73:792-9.
4. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
5. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretriviral therapy. J Natl Cancer Inst 2005;97:425-32.
6. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy. The Swiss HIV cohort study. JAMA 1999;282:2220-6.
7. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003;32:527-33.
8. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823-30.
9. Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Goedert JJ, Blattner WA. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer 1997;73:645-50.
10. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-9.
11. Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000;356:291-6.
12. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285: 1736-45.
13. Uccini S, Monardo F, Ruco LP, Baroni CD, Faggioni A, Agliano AM, Gradilone A, Manzari V, Vago L, Costanzi G, Carbone A, Boiochhi M, De Re V. High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1989;1:1458.
14. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92: 1500-10.
15. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002;31:536-41.
16. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
17. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-41.
18. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999;13:839-43.
19. Biggar RJ, Kirby KA, Atkinson J, McNeel TS, Engels E. Cancer risk in elderly persons with HIV/AIDS. J Acquir Immune Defic Syndr 2004;36:861-8.